COVID-19 associated mucormycosis: the urgent need to reconsider the indiscriminate use of immunosuppressive drugs

Alfonso J. Rodriguez-Morales; Ranjit Sah; Jose Millan-Oñate; Angel Gonzalez; Juan J. Montenegro-Idrogo; Sias Scherger; Carlos Franco-Paredes; Andrés F. Henao-Martínez

doi:10.1177/20499361211027065

COVID-19 associated mucormycosis: the urgent need to reconsider the indiscriminate use of immunosuppressive drugs

Alfonso J. Rodriguez-Morales, Ranjit Sah, Jose Millan-Oñate, Angel Gonzalez, Juan J. Montenegro-Idrogo, Sias Scherger, Carlos Franco-Paredes, Andrés F. Henao-Martínez

Medicina humana

Research output: Contribution to journal › Editorial

24 Scopus citations

Original language	English
Journal	Therapeutic Advances in Infectious Disease
Volume	8
DOIs	https://doi.org/10.1177/20499361211027065
State	Published - 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1177/20499361211027065

Cite this

@article{1a82b61a34b3402c8c83f93862873dc1,

title = "COVID-19 associated mucormycosis: the urgent need to reconsider the indiscriminate use of immunosuppressive drugs",

author = "Rodriguez-Morales, {Alfonso J.} and Ranjit Sah and Jose Millan-O{\~n}ate and Angel Gonzalez and Montenegro-Idrogo, {Juan J.} and Sias Scherger and Carlos Franco-Paredes and Henao-Mart{\'i}nez, {Andr{\'e}s F.}",

note = "Funding Information: We dedicate this Editorial to the memory of Dr. Francisco Miguel Marty, who died tragically in 2021. Dr. Marty is remembered as a gentle, well-rounded individual with extensive expertise in mucormycosis and other opportunistic infections, including mucormycosis in organ transplant recipients and patients with malignancies. This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.",

year = "2021",

doi = "10.1177/20499361211027065",

language = "Ingl{\'e}s",

volume = "8",

journal = "Therapeutic Advances in Infectious Disease",

issn = "2049-9361",

publisher = "SAGE Publications Inc.",

}

TY - JOUR

T1 - COVID-19 associated mucormycosis

T2 - the urgent need to reconsider the indiscriminate use of immunosuppressive drugs

AU - Rodriguez-Morales, Alfonso J.

AU - Sah, Ranjit

AU - Millan-Oñate, Jose

AU - Gonzalez, Angel

AU - Montenegro-Idrogo, Juan J.

AU - Scherger, Sias

AU - Franco-Paredes, Carlos

AU - Henao-Martínez, Andrés F.

N1 - Funding Information: We dedicate this Editorial to the memory of Dr. Francisco Miguel Marty, who died tragically in 2021. Dr. Marty is remembered as a gentle, well-rounded individual with extensive expertise in mucormycosis and other opportunistic infections, including mucormycosis in organ transplant recipients and patients with malignancies. This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

PY - 2021

Y1 - 2021

UR - http://www.scopus.com/inward/record.url?scp=85108180495&partnerID=8YFLogxK

U2 - 10.1177/20499361211027065

DO - 10.1177/20499361211027065

M3 - Editorial

AN - SCOPUS:85108180495

SN - 2049-9361

VL - 8

JO - Therapeutic Advances in Infectious Disease

JF - Therapeutic Advances in Infectious Disease

ER -

COVID-19 associated mucormycosis: the urgent need to reconsider the indiscriminate use of immunosuppressive drugs

UN SDGs

Access to Document

Other files and links

Cite this